Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
143.4 USD | +1.26% | +3.70% | +0.53% |
05-08 | Visa, PNC, Synchrony Among Companies Targeted in Cyberattack Campaign | MT |
05-08 | Bernstein Adjusts Clorox's Price Target to $155 From $162, Keeps Market Perform Rating | MT |
Sales 2024 * | 7.17B 573B | Sales 2025 * | 7.38B 590B | Capitalization | 17.8B 1,422B |
---|---|---|---|---|---|
Net income 2024 * | 324M 25.88B | Net income 2025 * | 725M 57.9B | EV / Sales 2024 * | 2.8 x |
Net Debt 2024 * | 2.26B 180B | Net Debt 2025 * | 2.26B 180B | EV / Sales 2025 * | 2.72 x |
P/E ratio 2024 * |
57
x | P/E ratio 2025 * |
24.4
x | Employees | 8,100 |
Yield 2024 * |
3.34% | Yield 2025 * |
3.49% | Free-Float | 94.83% |
Latest transcript on The Clorox Company
1 day | +1.26% | ||
1 week | +3.70% | ||
Current month | -3.06% | ||
1 month | -1.00% | ||
3 months | -6.43% | ||
6 months | +7.41% | ||
Current year | +0.53% |
Managers | Title | Age | Since |
---|---|---|---|
Linda Rendle
CEO | Chief Executive Officer | 46 | 31/12/02 |
Kevin Jacobsen
DFI | Director of Finance/CFO | 57 | 31/12/94 |
Michael Ott
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Allan Mackay
BRD | Director/Board Member | 68 | 14/08/16 |
Director/Board Member | 71 | 30/06/15 | |
Director/Board Member | 66 | 30/06/15 |
Date | Price | Change | Volume |
---|---|---|---|
10/05/24 | 143.4 | +1.26% | 1,239,835 |
09/05/24 | 141.6 | +0.81% | 816,418 |
08/05/24 | 140.4 | -0.53% | 1,169,176 |
07/05/24 | 141.2 | +1.36% | 1,154,444 |
06/05/24 | 139.3 | +0.76% | 1,254,212 |
Delayed Quote Nyse, May 10, 2024 at 09:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.53% | 17.8B | |
-15.18% | 40.49B | |
+13.48% | 26.24B | |
+9.39% | 6.17B | |
-27.48% | 6.08B | |
-2.92% | 3.15B | |
+0.92% | 2.34B | |
-3.80% | 2.02B | |
+26.43% | 940M | |
-0.88% | 645M |
- Stock Market
- Equities
- CLX Stock